Max Healthcare Institute Reports Q1 Results and Approves Major Capital Expenditure for Hospital Expansion

Max Healthcare Institute Reports Q1 Results and Approves Major Capital Expenditure for Hospital Expansion​

Max Healthcare Institute Limited announced its unaudited financial results for the quarter ended June 30, 2026, alongside several major corporate updates, including approval of a significant capital expenditure aimed at expanding its super speciality hospital in Vaishali. The company also shared updates regarding key management personnel appointments and staff transitions.

The Board of Directors approved the consolidated and standalone financial results, which were reviewed by M/s. S.R. Batliboi & Co. LLP, the Statutory Auditors.

Financial Performance Highlights​

For the quarter ended June 30, 2026, Max Healthcare Institute reported solid consolidated performance. Total income stood at ₹2,40,669 lakhs, driven by a revenue from operations of ₹2,36,617 lakhs. The company posted a profit for the period amounting to ₹32,296 lakhs.

The unaudited standalone results also showed strength, with total income reaching ₹87,502 lakhs and a profit for the period of ₹16,760 lakhs.

Financial data comparing the quarter ended June 30, 2026, against previous periods is presented below:

Strategic Expansion and Future Growth​

In a move signalling aggressive growth plans, the Board accorded in-principle approval for a capital expenditure (CapEx) of up to ₹425 Crore. This investment is dedicated to the construction of an additional hospital block, 'Tower 3', at Max Super Speciality Hospital, Vaishali. The project involves developing and equipping Tower 3 on approximately one acre of land contiguous to the existing facility.

Furthermore, the company has initiated exploration into setting up medical colleges or medical institutions. This decision follows a review of proposals in light of potential regulatory amendments by the National Medical Commission (NMC). In line with its long-term strategy, the Board also approved an amendment to the Memorandum of Association incorporating additional enabling business objects.

Management Personnel Updates​

Max Healthcare Institute Limited made several updates regarding its senior management team during the board meeting on August 13, 2026.

Appointments:

• Mr. Ajay Vij was appointed as Director - Chief Supply Chain & Procurement Officer, effective August 14, 2026. Mr. Vij brings over 35 years of experience across healthcare, retail, and manufacturing sectors.
• Mr. Pawan Kumar Marella was appointed as Senior Director - Chief Experience & Brand Officer, effective August 17, 2026. Mr. Marella has more than 22 years of experience in commercial strategy and marketing leadership globally.

Resignation:
Dr. N. Venkatesan resigned from his post as Senior Director and Chief Procurement Officer. His resignation is effective from the closing hours on August 31, 2026.

MAXHEALTH Stock Price Movement​

Shares of Max Healthcare Institute Limited shed 1.04% in post-market activity today, settling near the previous close at ₹997. The stock recorded a solid trading session, with total traded volume coming to approximately 1.08 million shares.